[ASND] Ascendis Pharma A/S

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 19.87 Change: -0.14 (-0.7%)
Ext. hours: Change: 0 (0%)

chart ASND

Refresh chart

Strongest Trends Summary For ASND

ASND is in the long-term up 57% in 3 years and up 482% in 5 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Fundamental Ratios
Shares Outstanding EPS-2.56 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -64.77% Sales Growth - Q/Q-64.77% P/E-9.38
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-3.8% ROE-4.87% ROI
Current Ratio4.13 Quick Ratio Long Term Debt/Equity Debt Ratio0.28
Gross Margin Operating Margin-46.7% Net Profit Margin-24.89% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities47.91 M Cash From Investing Activities-410 K Cash From Operating Activities-18.4 M Gross Profit
Net Profit-5.04 M Operating Profit-7.06 M Total Assets58.67 M Total Current Assets53.16 M
Total Current Liabilities12.86 M Total Debt Total Liabilities12.86 M Total Revenue2.83 M
Technical Data
High 52 week132.09 Low 52 week55.16 Last close100.72 Last change6.46%
RSI46.72 Average true range4.19 Beta0.84 Volume16.12 K
Simple moving average 20 days2.36% Simple moving average 50 days-5.12% Simple moving average 200 days-4.64%
Performance Data
Performance Week8.84% Performance Month-4.06% Performance Quart-10.68% Performance Half-9.7%
Performance Year68.32% Performance Year-to-date60.77% Volatility daily2.72% Volatility weekly6.09%
Volatility monthly12.47% Volatility yearly43.2% Relative Volume225.05% Average Volume214.06 K
New High New Low

News

2020-05-22 06:14:14 | Earnings Beat: Ascendis Pharma A/S NASDAQ:ASND Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

2020-05-19 16:01:10 | Ascendis Pharma A/S Reports First Quarter 2020 Financial Results

2020-05-19 14:30:00 | Ascendis Pharma A/S to Host Earnings Call

2020-05-11 08:30:10 | Ascendis Pharma A/S Will Appoint Jesper Høiland as Global Chief Commercial Officer

2020-05-08 11:46:06 | 7 “Strong Buy” Healthcare Stocks to Buy Now

2020-05-07 16:01:10 | Ascendis Pharma A/S Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 19

2020-04-21 06:01:03 | Ascendis Pharma A/S NASDAQ:ASND Analysts Just Slashed This Year's Revenue Estimates By 12%

2020-04-19 16:00:10 | Ascendis Pharma A/S Announces Top-line Data from Fixed Dose Portion of Phase 2 Trial Demonstrating Potential of TransCon™ PTH as a Replacement Therapy for Hypoparathyroidism

2020-04-15 16:58:36 | Ascendis Pharma A/S Receives Orphan Drug Designation for TransCon™ hGH as Treatment for Growth Hormone Deficiency in the United States

2020-04-02 09:44:39 | Edited Transcript of ASND earnings conference call or presentation 1-Apr-20 8:30pm GMT

2020-04-01 16:01:10 | Ascendis Pharma A/S Reports Full-Year 2019 Financial Results

2020-03-25 16:01:10 | Ascendis Pharma A/S Announces Full Year 2019 Financial Results and Business Update Conference Call on April 1

2020-03-22 20:25:13 | Hedge Funds Have Never Been This Bullish On Ascendis Pharma A/S ASND

2020-03-21 08:49:42 | We're Hopeful That Ascendis Pharma NASDAQ:ASND Will Use Its Cash Wisely

2020-03-17 12:00:04 | Ascendis Pharma A/S ASND Moves to Buy: Rationale Behind the Upgrade

2020-02-12 16:01:10 | Ascendis Pharma A/S Announces Upcoming Investor Presentation in February

2020-02-10 09:28:02 | Alkermes ALKS to Report Q4 Earnings: What's in Store?

2020-02-10 09:25:02 | Zoetis ZTS to Report Q4 Earnings: What's in the Cards?

2020-02-06 10:44:03 | Emmaus EMMA to Report Q4 Earnings: What's in the Cards?

2020-02-04 11:28:18 | Vanguard Health Care Fund Adds 4 Stocks to Portfolio in 4th Quarter

2020-01-21 05:21:16 | Shareholders Are Raving About How The Ascendis Pharma NASDAQ:ASND Share Price Increased 554%

2020-01-12 19:45:10 | Ascendis Pharma A/S Provides Pipeline Update and Reviews Progress Towards Vision 3x3 at 38th Annual J.P. Morgan Healthcare Conference

2020-01-09 16:00:10 | Ascendis Pharma A/S Announces Participation in 38th Annual J.P. Morgan Healthcare Conference

2019-12-26 11:26:20 | How Did Ascendis Pharma A/S ASND Compare Against Hedge Fund Darlings in 2019?

2019-12-04 12:42:34 | Here’s What Hedge Funds Think About Ascendis Pharma A/S ASND

2019-11-22 05:38:37 | Ascendis Pharma A/S Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates

2019-11-21 09:05:02 | Top Ranked Momentum Stocks to Buy for November 21st

2019-11-19 01:58:42 | Edited Transcript of ASND earnings conference call or presentation 18-Nov-19 9:30pm GMT

2019-11-18 16:01:00 | Ascendis Pharma A/S Reports Third Quarter 2019 Financial Results

2019-11-18 10:33:51 | Top Ranked Momentum Stocks to Buy for November 18th

2019-11-18 01:02:30 | New Records and New Milestones

2019-11-14 16:01:00 | Ascendis Pharma Expands TransCon™ PTH Phase 2 PaTH Forward Clinical Trial to Expedite Enrollment of Subjects Previously Treated with NATPARA® in the United States

2019-11-12 09:52:02 | What's in Store for Helmerich & Payne HP in Q4 Earnings?

2019-11-11 07:50:12 | 5 Biotech Stocks Set to Beat Q3 Earnings Estimates

2019-11-08 16:02:00 | Ascendis Pharma A/S Announces Upcoming Investor Presentation in November

2019-11-06 16:02:00 | Ascendis Pharma A/S Announces First Presentation of Preclinical Data Utilizing TransCon™ Technology in Oncology at SITC 2019

2019-11-05 11:50:04 | CannTrust CTST to Report Q3 Earnings: What's in Store?

2019-11-05 11:13:04 | Zoetis ZTS to Report Q3 Earnings: What's in the Cards?

2019-11-04 18:30:00 | Ascendis Pharma A/S Announces Third Quarter 2019 Financial Results and Business Update Conference Call on November 18

2019-10-29 09:00:01 | Ascendis Pharma A/S ASND Upgraded to Buy: Here's Why

2019-10-24 11:47:00 | How to invest in biotech stocks like a Nobel Prize winner

2019-10-21 16:04:59 | Ascendis Pharma A/S Receives Orphan Designation for TransCon™ hGH for the Treatment of Pediatric Growth Hormone Deficiency in Europe

2019-10-14 20:44:59 | Here’s What Hedge Funds Think About Ascendis Pharma A/S ASND

2019-09-26 08:25:00 | Ascendis Pharma A/S Announces Upcoming Investor Presentation in October

2019-09-19 08:30:53 | When Will Ascendis Pharma A/S NASDAQ:ASND Run Out Of Money?

2019-09-12 16:20:00 | Ascendis Pharma A/S Announces Presentations on Achondroplasia and TransCon™ CNP at International Skeletal Dysplasia Society Meeting

2019-09-03 03:20:51 | 3 Biopharma Stocks With Over 50% Upside

2019-08-29 17:15:00 | Ascendis Pharma A/S Announces Three Investor Presentations in September

2019-08-29 06:19:08 | Edited Transcript of ASND earnings conference call or presentation 28-Aug-19 8:30pm GMT

2019-08-29 04:23:30 | Ascendis Pharma A/S ASND Q2 2019 Earnings Call Transcript